Though DNAH8 and ESM1 have previously been associated with prostate cancer they were not found to be BCR-free survival related DEGs in the post-hoc analysis and only ESM1 was found to be associated with a clinical variable (biopsy Gleason score). Here, ESM1 is linked to prostate cancer.